NEW YORK, Oct. 10 – Qiagen said on Wednesday that it has received an exclusive license to market and distribute Kreatech Biotechnology’s ULS labeling technologies in combination with its resonance light scattering products.

In addition, Qiagen acquired non-exclusive rights to develop and sell ULS products for labeling and detecting nucleic acids and proteins in microarray experiments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.